← HB3057 bill details

Other recorded roll call

HB3057

Three day rule suspended

Relating to health benefit plan coverage for chimeric antigen receptor T-cell therapy.

Failed Senate May 27, 2025

0Yea
1Nay
0Not voting
0Absent

Nay (1)

Source provenance